May 12, 2025
Tango Therapeutics
Tango Therapeutics Reports First Quarter 2025 Financial ResultsĀ and Provides Business Highlights
May 08, 2025
Synnovation Therapeutics
Synnovation Therapeutics Announces the Appointment of Rafael G. Amado, M.D., to Its Board of Directors
May 07, 2025
Marea Therapeutics
Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress
May 01, 2025
Tango Therapeutics
Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
April 28, 2025
Clasp Therapeutics
Clasp Therapeutics Doses First Patient in Phase 1 Clinical Trial with a First-in-Class T-Cell Engager Designed to Target Cancer Cells with Absolute Specificity